BibTex RIS Kaynak Göster

Incomplete Kawasaki Disease Probable Associated with COVID-19: A Case Report

Yıl 2021, , 56 - 59, 25.08.2021
https://doi.org/10.51261/yiu.2021.00030

Öz

Kawasaki disease is an acute systemic inflammatory disease affecting the medium and small vessels mostly in children under 5 years old. Although SARS-CoV2 less severely affects children, with the rapid spread of disease some new clinical aspects like Kawasaki-like disease have been reported in children affected by COVID-19. Here in we present a child with incomplete Kawasaki disease probably associated with COVID-19.

Kaynakça

  • Pouletty M, Borocco C, Ouldani N, Caseris M, Basmaci R, Lachaume N et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS- COV-2 mimicking Kawasaki disease Kawa-COVID-19 : a multicentre cohort. Ann Rheum Dis. 2020;79:2.
  • Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al. Anoutbreak of severe Kawasaki-like disease at Italian epicentre of the SARS- CoV-2 epidemic: an observational cohort study. Lancet. 2020 6-12; 395: 1771– 1778
  • Kawasaki T. Proc Jpn Acad Ser B Phys Biol Sci. 2006; 82:59–71.
  • Greco A, De Virglio A, Rizzo MI, Tombolini M, Gallo A, fusconi M, et al. Kawasaki disease an evolving paradigim. Autoimmun Rev 2015;14:703-9.
  • JCS Joint Working Group, Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease JCS 2013 . Digest version Circ J. 2014;78:2521-62 .
  • Mc Crindle BW, Rowley AH, Newburger JW al. Diagnosis, treatment and long-term management of Kawasaki disease: a scientefic statement for health professionals from the American heart association. Circulation 2017;135:104-7
  • Sanchez-Manubens J, Bou R, Anton J. Diagnosis and classification of Kawasaki disease Autoimmun 2014;48-49:113-7
  • Kato H. Cardiovascular complications in Kawasaki disease coronary artery lumen and long-term consequences. Progress Pediatr Cardiol 2004;19:137-45.
  • Uehara R, Igarashi H, Yashiro M, Nakamura, Yanagawa H; Kawasaki disease patients with rednes or crust formation at the Bacille Calmette-Guérin inoculation site.The Pediatric İnfectious Disease Journal. 2010; 29:430-433.
  • Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in US Children and adolescents. N Engl J Med. 2020;383:334–346. doi:10.1056/NEJ Moa 2021680
  • Yang, Yang, et al. “Laboratory diagnosis and monitoring the viral shedding of 2019- nCoV infections.” medRxiv 2020 .
  • Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. 2020 doi:10.1002/art.414
  • Pascall B, Thakker A, Foo Y, Thakker P. Immunoglobulin for Kawasaki disease: a 3-year retrospective audit. BMJ Paediatrics Open 2019;3: E000451.
  • Dajani AS, Taubert KA, Gerber MA, Shulman ST. Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:177680
  • Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroides. J Pediatr 1996; 128:146-9.

COVID-19 ile Olası İlişkili İnkomplet Kawasaki Hastalığı: Olgu Sunumu

Yıl 2021, , 56 - 59, 25.08.2021
https://doi.org/10.51261/yiu.2021.00030

Öz

Kawasaki hastalığı,sıklıkla 5 yaş altı çocukları etkileyen , orta ve küçük damarların tutulumu ile seyreden akut inflamatuar bir hastalıktır. SARS-CoV2 çocuklarda ciddi hastalığa neden olmasa da, hastalığın hızlı yayılması ile COVID-19’dan etkilenen çocuklarda Kawasakibenzeri hastalık gibi yeni klinik durumlar görülmeye başlamıştır. Bu makalede COVID-19 ile olası ilişkili olduğunu düşündüğümüz bir inkomplet Kawasaki olgusu sunduk.

Kaynakça

  • Pouletty M, Borocco C, Ouldani N, Caseris M, Basmaci R, Lachaume N et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS- COV-2 mimicking Kawasaki disease Kawa-COVID-19 : a multicentre cohort. Ann Rheum Dis. 2020;79:2.
  • Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al. Anoutbreak of severe Kawasaki-like disease at Italian epicentre of the SARS- CoV-2 epidemic: an observational cohort study. Lancet. 2020 6-12; 395: 1771– 1778
  • Kawasaki T. Proc Jpn Acad Ser B Phys Biol Sci. 2006; 82:59–71.
  • Greco A, De Virglio A, Rizzo MI, Tombolini M, Gallo A, fusconi M, et al. Kawasaki disease an evolving paradigim. Autoimmun Rev 2015;14:703-9.
  • JCS Joint Working Group, Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease JCS 2013 . Digest version Circ J. 2014;78:2521-62 .
  • Mc Crindle BW, Rowley AH, Newburger JW al. Diagnosis, treatment and long-term management of Kawasaki disease: a scientefic statement for health professionals from the American heart association. Circulation 2017;135:104-7
  • Sanchez-Manubens J, Bou R, Anton J. Diagnosis and classification of Kawasaki disease Autoimmun 2014;48-49:113-7
  • Kato H. Cardiovascular complications in Kawasaki disease coronary artery lumen and long-term consequences. Progress Pediatr Cardiol 2004;19:137-45.
  • Uehara R, Igarashi H, Yashiro M, Nakamura, Yanagawa H; Kawasaki disease patients with rednes or crust formation at the Bacille Calmette-Guérin inoculation site.The Pediatric İnfectious Disease Journal. 2010; 29:430-433.
  • Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in US Children and adolescents. N Engl J Med. 2020;383:334–346. doi:10.1056/NEJ Moa 2021680
  • Yang, Yang, et al. “Laboratory diagnosis and monitoring the viral shedding of 2019- nCoV infections.” medRxiv 2020 .
  • Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. 2020 doi:10.1002/art.414
  • Pascall B, Thakker A, Foo Y, Thakker P. Immunoglobulin for Kawasaki disease: a 3-year retrospective audit. BMJ Paediatrics Open 2019;3: E000451.
  • Dajani AS, Taubert KA, Gerber MA, Shulman ST. Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:177680
  • Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroides. J Pediatr 1996; 128:146-9.
Toplam 15 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Olgu Sunumu
Yazarlar

Muzaffer Altıntaş

Engin Yurdakul

Feyza Ayşenur Paç

Meltem Refiker Ege

Yayımlanma Tarihi 25 Ağustos 2021
Yayımlandığı Sayı Yıl 2021

Kaynak Göster

AMA Altıntaş M, Yurdakul E, Paç FA, Ege MR. COVID-19 ile Olası İlişkili İnkomplet Kawasaki Hastalığı: Olgu Sunumu. YIU Saglik Bil Derg. Ağustos 2021;2(2):56-59. doi:10.51261/yiu.2021.00030